Publications by authors named "Haoling Zhu"

Claim this Profile
D
Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia.
Rose Parisi, Emily A Cowen, Joseph R Stoll, Haoling Zhu, Stephen Dusza

Leuk Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians.
Haoling Zhu, Başak E Doğan

Eur J Breast Health· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There a Difference in the Diagnostic Outcomes of Calcifications Initially Identified on Synthetic Tomosynthesis Versus Full-Field Digital Mammography Screening?
Haoling Zhu, Dogan Polat, Phil Evans, Ann Mootz, Timothy Blackburn

Eur J Radiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia.
Shruti Bhatt, Marissa S Pioso, Elyse Anne Olesinski, Binyam Yilma, Jeremy A Ryan, Haoling Zhu

Cancer Cell· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells.
Josephine D Kahn, Peter G Miller, Alexander J Silver, Rob S Sellar, Shruti Bhatt, Haoling Zhu

Blood· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis